US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 38.060
  • +0.630+1.68%
Close Jan 8 16:00 ET
  • 37.510
  • -0.550-1.45%
Pre 04:13 ET
2.10BMarket Cap35.67P/E (TTM)

Supernus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 143.450M--
--2024/Q4-- / 154.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
May 8, 20242024/Q1143.644M / 145.832M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 143.450M--
--2024/Q4-- / 154.252M--
Nov 4, 20242024/Q3175.689M / 157.298M--
Aug 6, 20242024/Q2168.325M / 148.852M--
May 8, 20242024/Q1143.644M / 145.832M--

Unlock Free Earnings Estimates

Supernus Pharmaceuticals Earnings Reports

  • Supernus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 4, 2024 16:24 ET

  • Supernus Pharmaceuticals | 8-K: Supernus Announces Third Quarter 2024 Financial Results

    Nov 4, 2024 16:15 ET

  • Supernus Pharmaceuticals | 8-K: Supernus Announces Second Quarter 2024 Financial Results

    Aug 6, 2024 16:38 ET

  • Supernus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 6, 2025

    Buy

    • Buy

      60.00%

    • Hold

      40.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data